Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Up 2.9%

Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF) shot up 2.9% during mid-day trading on Wednesday . The company traded as high as $1.78 and last traded at $1.78. 195,473 shares changed hands during trading, an increase of 191% from the average session volume of 67,097 shares. The stock had previously closed at $1.73.

The business’s 50-day moving average price is $2.06 and its 200-day moving average price is $2.81.

Cardiol Therapeutics Company Profile (OTCMKTS:CRTPF)

Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.

Further Reading: Why is the ROA ratio important?

Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.